357 related articles for article (PubMed ID: 31571815)
1. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.
Massa H; Pipis SY; Adewoyin T; Vergados A; Patra S; Panos GD
Clin Ophthalmol; 2019; 13():1761-1777. PubMed ID: 31571815
[TBL] [Abstract][Full Text] [Related]
2. Update in treatment of uveitic macular edema.
Koronis S; Stavrakas P; Balidis M; Kozeis N; Tranos PG
Drug Des Devel Ther; 2019; 13():667-680. PubMed ID: 30858697
[TBL] [Abstract][Full Text] [Related]
3. [Uveitic macular edema and the pharmacotherapy].
Liu X; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):151-4. PubMed ID: 25908007
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion on the use of biological therapy in non-infectious uveitis.
Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):687-698. PubMed ID: 29610003
[TBL] [Abstract][Full Text] [Related]
6. Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Leclercq M; Andrillon A; Maalouf G; Sève P; Bielefeld P; Gueudry J; Sené T; Moulinet T; Rouvière B; Sène D; Desbois AC; Domont F; Touhami S; El Chamieh C; Cacoub P; Bodaghi B; Biard L; Saadoun D
Ophthalmology; 2022 May; 129(5):520-529. PubMed ID: 34793830
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review.
Gómez-Gómez A; Loza E; Rosario MP; Espinosa G; de Morales JMGR; Herrera JM; Muñoz-Fernández S; Rodríguez-Rodríguez L; Cordero-Coma M;
Semin Arthritis Rheum; 2020 Dec; 50(6):1299-1306. PubMed ID: 33065425
[TBL] [Abstract][Full Text] [Related]
8. Disease of the Year: Differential Diagnosis of Uveitic Macular Edema.
Agarwal A; Pichi F; Invernizzi A; Gupta V
Ocul Immunol Inflamm; 2019; 27(1):72-88. PubMed ID: 30273513
[TBL] [Abstract][Full Text] [Related]
9. INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema.
Lejoyeux R; Diwo E; Vallet H; Saadoun D; Tezenas du Montcel S; Bodaghi B; LeHoang P; Fardeau C
Ocul Immunol Inflamm; 2018; 26(7):991-996. PubMed ID: 30096013
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.
Fabiani C; Vitale A; Rigante D; Emmi G; Bitossi A; Lopalco G; Sota J; Guerriero S; Orlando I; Gentileschi S; Iannone F; Frediani B; Galeazzi M; Vannozzi L; Tosi GM; Cantarini L
Clin Rheumatol; 2019 Feb; 38(2):407-415. PubMed ID: 30099655
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
12. Uveitic macular edema.
Fardeau C; Champion E; Massamba N; LeHoang P
Eye (Lond); 2016 Oct; 30(10):1277-1292. PubMed ID: 27256304
[TBL] [Abstract][Full Text] [Related]
13. New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.
Valenzuela RA; Flores I; Urrutia B; Fuentes F; Sabat PE; Llanos C; Cuitino L; Urzua CA
Front Pharmacol; 2020; 11():655. PubMed ID: 32508634
[TBL] [Abstract][Full Text] [Related]
14. Update on the Management of Uveitic Macular Edema.
Teper SJ
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575244
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis and uveitis.
Jamilloux Y; Kodjikian L; Broussolle C; Sève P
Autoimmun Rev; 2014 Aug; 13(8):840-9. PubMed ID: 24704868
[TBL] [Abstract][Full Text] [Related]
16. The Use of Topical Non-steroidal Anti-inflammatory Drugs for Uveitic Cystoid Macular Edema.
Petrushkin H; Rogers D; Pavesio C
Ocul Immunol Inflamm; 2018; 26(5):795-797. PubMed ID: 28080174
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
[TBL] [Abstract][Full Text] [Related]
18. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
19. Emerging therapies in the management of macular edema: a review.
Sacconi R; Giuffrè C; Corbelli E; Borrelli E; Querques G; Bandello F
F1000Res; 2019; 8():. PubMed ID: 31448093
[TBL] [Abstract][Full Text] [Related]
20. An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.
Sood AB; Angeles-Han ST
Curr Treatm Opt Rheumatol; 2017 Mar; 3(1):1-16. PubMed ID: 28944162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
